BML-275 Chemical Properties

storage temp. 

under inert gas (nitrogen or Argon) at 2-8°C

solubility 

insoluble in EtOH; insoluble in H2O; ≥11.34 mg/mL in 0.9% NS ; ≥39.93 mg/mL in DMSO:H2O=2:1 ; ≥5.91 mg/mL in DMSO

form 

Light yellow powder solid.

color 

Yellow

Stability:

Hygroscopic

BML-275 Usage And Synthesis

Description

Dorsomorphin (hydrochloride) is a potent, reversible inhibitor of AMP kinase (AMPK; K_i = 109 nM) that does not exhibit significant activity on structurally related kinases, including ZAPK, SYK, PKCθ, PKA, and JAK3. Dorsomorphin can also dose-dependently inhibit the bone morphogenetic protein type 1 receptors ACTR-I (ALK2), BMPR-IA (ALK3), and BMPR-IB (ALK6). Independent of AMPK inhibition, dorsomorphin, at 10 μM, has additionally been shown to downregulate the Akt/mTOR pathway to induce autophagy in U251 human glioma cells.

Uses

Dorsomorphin is an AMP-activated kinase (AMPK) inhibitor. Dorsomorphin selectively inhibits the bone morphogenetic protein (BMP) type I receptors ALK2, ALK3 and ALK6 and thus blocks BMP-mediated SMAD1/5/8 phosphorylation, target gene transcription and osteogenic differentiation. Dorsomorphin has shown to increase cisplatin-induced apoptosis, which was associated with hyper-induction of the tumor suppressor p53.

storage

Room temperature (desiccate)

BML-275(1219168-18-9)Related Product Information

• D-ERYTHRO-SPHINGOSINE
• 3-METHYLADENINE
• SB 431542
• A 769662
• AICAR
• LY 294002 HYDROCHLORIDE
• Rapamycin
• KU-55933
• Selumetinib
• PLX-4720
• CX-4945
• Fluoxetine hydrochloride
• Alpelisib (BYL719)
• Tubastatin A hydrochloride
• N-[5-[[[5-(1,1-Dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4-piperidinecarboxamide hydrochloride
• BI 2536
• Neratinib
• Glucagon Receptor Antagonist I